MELBOURNE, Australiaâ€”Australia's antitrust regulator has launched court proceedings against the local arm of Pfizer Inc. alleging it misused its market power in the sale of a popular cholesterol-lowering drug.. The Australian Competition and Consumer Commission in a statement Thursday said its action in the federal court relates to offers made to drugstores in early 2012 for the supply of Lipitor and Pfizer's generic variant, atorvastatin.